The Promise of Biological Markers for Treatment Response in First-Episode Psychosis: A Systematic Review
出版年份 2015 全文链接
标题
The Promise of Biological Markers for Treatment Response in First-Episode Psychosis: A Systematic Review
作者
关键词
-
出版物
SCHIZOPHRENIA BULLETIN
Volume 41, Issue 3, Pages 559-573
出版商
Oxford University Press (OUP)
发表日期
2015-03-11
DOI
10.1093/schbul/sbv002
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Serological Documentation of Maternal Influenza Exposure and Bipolar Disorder in Adult Offspring
- (2014) Sarah E. Canetta et al. AMERICAN JOURNAL OF PSYCHIATRY
- A neurobiological hypothesis for the classification of schizophrenia: type a (hyperdopaminergic) and type B (normodopaminergic)
- (2014) Oliver D. Howes et al. BRITISH JOURNAL OF PSYCHIATRY
- Functional Analysis via Standardized Whole-Blood Stimulation Systems Defines the Boundaries of a Healthy Immune Response to Complex Stimuli
- (2014) Darragh Duffy et al. IMMUNITY
- Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients
- (2014) Hans Rasmussen et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The effect of artemether on psychotic symptoms and cognitive impairment in first-episode, antipsychotic drug-naive persons with schizophrenia seropositive to Toxoplasma gondii
- (2014) Hui-Ling Wang et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Genome-wide association study supports the role of the immunological system and of the neurodevelopmental processes in response to haloperidol treatment
- (2014) Antonio Drago et al. Pharmacogenetics and Genomics
- Activation of Th17 cells in drug naïve, first episode schizophrenia
- (2014) Minli Ding et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effects of vitamin D receptor polymorphisms on the risk of schizophrenia and metabolic changes caused by risperidone treatment
- (2014) Pei Jiang et al. PSYCHIATRY RESEARCH
- Morning cortisol levels in schizophrenia and bipolar disorder: A meta-analysis
- (2014) Leah Girshkin et al. PSYCHONEUROENDOCRINOLOGY
- Cortisol awakening response and diurnal cortisol among children at elevated risk for schizophrenia: Relationship to psychosocial stress and cognition
- (2014) Alexis E. Cullen et al. PSYCHONEUROENDOCRINOLOGY
- Impaired Metabolic Reactivity to Oxidative Stress in Early Psychosis Patients
- (2014) Margot Fournier et al. SCHIZOPHRENIA BULLETIN
- Reduced Levels of Vasopressin and Reduced Behavioral Modulation of Oxytocin in Psychotic Disorders
- (2014) Leah H. Rubin et al. SCHIZOPHRENIA BULLETIN
- The impact of second-generation antipsychotic adherence on positive and negative symptoms in recent-onset schizophrenia
- (2014) Kenneth L. Subotnik et al. SCHIZOPHRENIA RESEARCH
- Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment
- (2014) Lot de Witte et al. SCHIZOPHRENIA RESEARCH
- A longitudinal study on the relationship between duration of untreated psychosis and executive function in early-onset first-episode psychosis
- (2014) David Fraguas et al. SCHIZOPHRENIA RESEARCH
- Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis
- (2014) Rachel Upthegrove et al. SCHIZOPHRENIA RESEARCH
- Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study
- (2014) Mónica Martínez-Cengotitabengoa et al. SCHIZOPHRENIA RESEARCH
- Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: A double blind, randomized, controlled trial
- (2014) Fang Liu et al. SCHIZOPHRENIA RESEARCH
- Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review
- (2013) G. Fond et al. ACTA PSYCHIATRICA SCANDINAVICA
- Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
- (2013) Arsime Demjaha et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cortisol Levels and Risk for Psychosis: Initial Findings from the North American Prodrome Longitudinal Study
- (2013) Elaine F. Walker et al. BIOLOGICAL PSYCHIATRY
- Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function
- (2013) Arsime Demjaha et al. BIOLOGICAL PSYCHIATRY
- Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate
- (2013) Guillaume Fond et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis
- (2013) S Smesny et al. MOLECULAR PSYCHIATRY
- Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid
- (2013) J J Luykx et al. MOLECULAR PSYCHIATRY
- Innovative solutions to novel drug development in mental health
- (2013) T.R. Insel et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Distinct Molecular Phenotypes in Male and Female Schizophrenia Patients
- (2013) Jordan M. Ramsey et al. PLoS One
- Extended duration of hospitalization in first episode psychosis: An evaluation of its clinical justification
- (2013) Delphine Capdevielle et al. PSYCHIATRY RESEARCH
- CYP450 Pharmacogenetic treatment strategies for antipsychotics: A review of the evidence
- (2013) Dana Ravyn et al. SCHIZOPHRENIA RESEARCH
- Antipsychotics' effects on blood levels of cytokines in schizophrenia: A meta-analysis
- (2013) Valérie Tourjman et al. SCHIZOPHRENIA RESEARCH
- Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight
- (2013) Xueqin Song et al. SCHIZOPHRENIA RESEARCH
- Peripheral vasopressin but not oxytocin relates to severity of acute psychosis in women with acutely-ill untreated first-episode psychosis
- (2013) Leah H. Rubin et al. SCHIZOPHRENIA RESEARCH
- The comparison of glycometabolism parameters and lipid profiles between drug-naïve, first-episode schizophrenia patients and healthy controls
- (2013) Xiaoli Wu et al. SCHIZOPHRENIA RESEARCH
- Duration of untreated bipolar disorder: missed opportunities on the long road to optimal treatment
- (2012) N. Drancourt et al. ACTA PSYCHIATRICA SCANDINAVICA
- The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
- (2012) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- Serum and gene expression profile of cytokines in first-episode psychosis
- (2012) Marco Di Nicola et al. BRAIN BEHAVIOR AND IMMUNITY
- Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism
- (2012) Alan S. Brown Developmental Neurobiology
- Pharmacogenetics of antipsychotics: recent progress and methodological issues
- (2012) Jian-Ping Zhang et al. Expert Opinion on Drug Metabolism & Toxicology
- Metabolomic Analysis of Biochemical Changes in the Plasma and Urine of First-Episode Neuroleptic-Naïve Schizophrenia Patients after Treatment with Risperidone
- (2012) Hua-Lin Cai et al. JOURNAL OF PROTEOME RESEARCH
- Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse
- (2012) Milica Borovcanin et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?
- (2012) S Kapur et al. MOLECULAR PSYCHIATRY
- Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia
- (2012) Emily G. Severance et al. NEUROBIOLOGY OF DISEASE
- Anterior Cingulate Glutamate Levels Related to Clinical Status Following Treatment in First-Episode Schizophrenia
- (2012) Alice Egerton et al. NEUROPSYCHOPHARMACOLOGY
- Treating patients with schizophrenia deficit with erythropoietin?
- (2012) Guillaume Fond et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Skin Ceramide Alterations in First-Episode Schizophrenia Indicate Abnormal Sphingolipid Metabolism
- (2012) Stefan Smesny et al. SCHIZOPHRENIA BULLETIN
- Polyunsaturated Fatty Acid Concentration Predicts Myelin Integrity in Early-Phase Psychosis
- (2012) B. D. Peters et al. SCHIZOPHRENIA BULLETIN
- Toxoplasma gondii and Other Risk Factors for Schizophrenia: An Update
- (2012) E. F. Torrey et al. SCHIZOPHRENIA BULLETIN
- Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study
- (2012) David Fraguas et al. SCHIZOPHRENIA RESEARCH
- Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
- (2011) Brian J. Miller et al. BIOLOGICAL PSYCHIATRY
- Reduced antioxidant defense in early onset first-episode psychosis: a case-control study
- (2011) Juan Antonio Micó et al. BMC Psychiatry
- Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients
- (2011) Monia Raffa et al. BMC Psychiatry
- Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation
- (2011) Karina S. MacDowell et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia
- (2011) Ruth Condray et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Oxytocin Revisited: Its Role in Cardiovascular Regulation
- (2011) J. Gutkowska et al. JOURNAL OF NEUROENDOCRINOLOGY
- Evaluation of Five Antischizophrenic Agents Against Toxoplasma gondii in Human Cell Cultures
- (2011) David G. Goodwin et al. JOURNAL OF PARASITOLOGY
- Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
- (2011) Andreas Meyer-Lindenberg et al. NATURE REVIEWS NEUROSCIENCE
- Update on Omega-3 Polyunsaturated Fatty Acids in Early-Stage Psychotic Disorders
- (2011) G Paul Amminger et al. NEUROPSYCHOPHARMACOLOGY
- Long-term (3-year) effectiveness of haloperidol, risperidone and olanzapine: results of a randomized, flexible-dose, open-label comparison in first-episode nonaffective psychosis
- (2011) Benedicto Crespo-Facorro et al. PSYCHOPHARMACOLOGY
- Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders
- (2010) G. Paul Amminger et al. ARCHIVES OF GENERAL PSYCHIATRY
- The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naïve patients with first-episode schizophrenia treated with risperidone
- (2010) Nikolina Jovanović et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Cortisol and dehydroepiandrosterone-sulphate levels correlate with symptom severity in first-episode psychosis
- (2010) Belinda Garner et al. JOURNAL OF PSYCHIATRIC RESEARCH
- DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia
- (2010) Todd Lencz et al. Pharmacogenetics and Genomics
- Serotonin transporter polymorphisms and early response to antipsychotic treatment in first episode of psychosis
- (2010) Javier Vázquez-Bourgon et al. PSYCHIATRY RESEARCH
- Catechol-O-methyltransferase Val158Met polymorphism and negative symptoms after acute antipsychotic treatment in first-episode non-affective psychosis
- (2010) José María Pelayo-Terán et al. PSYCHIATRY RESEARCH
- Neuroprotective effects of ethyl-eicosapentaenoic acid in first episode psychosis: A longitudinal T2 relaxometry pilot study
- (2010) Stephen J. Wood et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis
- (2010) M. Aas et al. PSYCHOLOGICAL MEDICINE
- Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment
- (2010) Norbert Müller et al. SCHIZOPHRENIA RESEARCH
- Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis
- (2010) Valeria Mondelli et al. SCHIZOPHRENIA RESEARCH
- A Danish National Birth Cohort study of maternal HSV-2 antibodies as a risk factor for schizophrenia in their offspring
- (2010) Preben B. Mortensen et al. SCHIZOPHRENIA RESEARCH
- Effect of Treatment on Weight Gain and Metabolic Abnormalities in Patients with First-Episode Psychosis
- (2009) Swapna Verma et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
- (2009) O. Howes et al. CURRENT PHARMACEUTICAL DESIGN
- DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis
- (2009) Rainald Mössner et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- DHEA and DHEA-S levels in hospitalized adolescents with first-episode schizophrenia and conduct disorder: A comparison study
- (2009) Rael D. Strous et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Metabolic Risk Factors in Drug-Naive Patients With First-Episode Psychosis
- (2009) Swapna K. Verma et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Double-Blind, Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase Schizophrenia
- (2009) Yechiel Levkovitz et al. JOURNAL OF CLINICAL PSYCHIATRY
- Common variants on chromosome 6p22.1 are associated with schizophrenia
- (2009) Jianxin Shi et al. NATURE
- Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
- (2009) Shaun M. Purcell et al. NATURE
- Common variants conferring risk of schizophrenia
- (2009) Hreinn Stefansson et al. NATURE
- Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients
- (2009) Immaculada Baeza et al. PSYCHIATRY RESEARCH
- Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: Implications for altered one-carbon metabolism
- (2009) Anvita Kale et al. PSYCHIATRY RESEARCH
- Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment
- (2009) Valeria Mondelli et al. SCHIZOPHRENIA RESEARCH
- Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia
- (2008) Masashi Ikeda et al. PHARMACOGENOMICS
- Pharmacokinetics of olanzapine in Chinese male schizophrenic patients with various smoking behaviors
- (2008) Tzu-Hua Wu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls?
- (2008) S SENGUPTA et al. SCHIZOPHRENIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now